Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7718610
Retrocyclins: antiviral and antimicrobial peptides
granted -
US 7714014
Targeting GLI proteins in human cancer by small molecules
granted -
US 7713721
Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
granted -
US 7713939
Illudin analogs useful as antitumor agents
granted -
US 7713526
Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
granted -
US 7713927
Antimicrobial peptides
granted -
US 7709517
Diarylhydantoin compounds
granted -
US 7705164
Metalloprotein inhibitors
granted -
US 7704701
Diagnosis of prostate cancer with SPAS-1 cancer antigen
granted -
US 7700738
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
granted -
US 7700127
Method and compositions for preparing and delivering rumen protected lipids, other nutrients and medicaments
granted -
US 7700547
Preventing airway mucus production by administration of EGF-R antagonists
granted -
US 7696244
Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof
granted -
US 7696227
Small-molecule inhibitors of the androgen receptor
granted -
US 7691965
Helical synthetic peptides that stimulate cellular cholesterol efflux
granted -
US 7691607
Expression system of NELL peptide
granted -
US 7687506
Selective serine/threonine kinase inhibitors
granted -
US 7687480
Phosphonate compounds
granted -
US 7687462
Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
granted -
US 7683041
Microgel particles for the delivery of bioactive materials
granted -
US 7682607
Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
granted -
US 7674249
Gels with predetermined conductivity used in electroporation of tissue
granted -
US 7670599
YKL-40 as a marker and prognostic indicator for cancers
granted -
US 7670855
Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
granted